AsclepiX Therapeutics nabs $35m Series A
New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing.
New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination